Table 1.
Demographics of Study Participants
| Characteristic | Arm | |||
|---|---|---|---|---|
| A (n = 15) | B (n = 16) | Total | P Valuea | |
| Age, y, median (IQR) | 47 (38.5–54.5) | 50.5 (45.5–55) | 49 (43.5–54.5) | .46 |
| Sex | .65 | |||
| Male | 12 (80.0) | 14 (87.5) | 26 (83.9) | |
| Female | 3 (20.0) | 2 (12.5) | 5 (16.1) | |
| Other | 0 (0) | 0 (0) | 0 (0) | |
| Race | .16 | |||
| Black | 10 (66.7) | 6 (37.5) | 16 (51.6) | |
| Not Black | 5 (33.3) | 10 (62.5) | 15 (48.4) | |
| CD4+ T-cell count, cells/µL, median (IQR) | 608 (513–756) | 556 (470–829) | 583 (479–803) | .92 |
| CD8+ T-cell count, cells/µL, median (IQR) | 704 (506–878) | 852.5 (638–989) | 711 (547–916) | .55 |
| Statin user | 4 (26.7) | 5 (31.2) | 9 (29.0) | 1.00 |
| ART class (in addition to NRTI backbone) | ||||
| PI | 6 (40.0) | 5 (31.2) | 11 (35.5) | .72 |
| INSTI | 3 (20.0) | 8 (50.0) | 11 (35.5) | .14 |
| NNRTI | 6 (40.0) | 6 (37.5) | 12 (38.7) | 1.00 |
| Viral load, copies/mL | ||||
| <20 | 14 (93.3) | 14 (87.5) | 28 (90.3) | 1.00 |
| 20 | 1 (6.7) | 2 (12.5) | 3 (9.7) | |
Data are presented as No. (%) unless otherwise indicated. Patients were randomized so any differences in variables would be by chance.
Abbreviations: ART, antiretroviral therapy; INSTI, integrase strand transfer inhibitor; IQR, interquartile range; NNRTI, nonnucleoside reverse transcriptase inhibitor; NRTI, nucleoside reverse transcriptase inhibitor; PI, protease inhibitor.
Comparisons were performed between arms using Mann-Whitney U test for continuous variables and Fisher exact tests for categorical variables.